Skip to main content
Site Logo
Search site
Search
Home
PDL / PA
Preferred Drug Lists
PA Forms
Prior Authorization Criteria
New Drug Process
Policy for Review of Drug Status
Appeals & Exception to Policy
CDC Guidelines
(External link)
Info Letters / Provider Info
Informational Letters
Latest news
Listserv
Fax Confidentiality Certificate
Billing Information
Billing / Quantity Limits
340B
Frequently Asked Questions
Payer Sheet
Committee / Public Comments
P&T Committee Information
Public Comments
Drugs for Rare Diseases
Rebate Info
Home
PDL / PA
Preferred Drug Lists
PA Forms
Prior Authorization Criteria
New Drug Process
Policy for Review of Drug Status
Appeals & Exception to Policy
CDC Guidelines
(External link)
Info Letters / Provider Info
Informational Letters
Latest news
Listserv
Fax Confidentiality Certificate
Billing Information
Billing / Quantity Limits
340B
Frequently Asked Questions
Payer Sheet
Committee / Public Comments
P&T Committee Information
Public Comments
Drugs for Rare Diseases
Rebate Info
Home
Section
P&T Committee Information
November 20, 2025
Related files
Tentative agenda
Draft PDL - November 20, 2025
Reports
There are no files currently available.
Drug mongraphs
Andembry
Anzupgo
Brinsupri
Harliku
Hernexeos
Modeyso
Sephience
Tryptyr
Vykat XR
Wakix
Yeztugo
Zelsuvmi
Zunveyl
Drug class reviews
There are no files currently available.
Archive
There are no files currently available.
keyboard_arrow_up
back to top
back to top
keyboard_arrow_up
